By staff writers

March 11, 2013 -- Radiopharmaceutical provider IBA Molecular North America is now producing zirconium-89 (Zr-89) at its radiopharmaceutical plant in Richmond, VA.

The radioisotope has a half-life of 78.41 hours and is utilized in specialized research and development applications using PET imaging. It will be available five days a week with direct door-to-door distribution in the U.S., according to the company.

Copyright © 2013

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking